Approval for the expansion of the indications for use of the crt-p and crt-d devices to include nyha functional class i, ii, or iii patients who have a left ventricular ejection fraction (lvef) =< 50% are on stable, optimal heart failure medical therapy if indicated, and have atrioventricular block (av block) that is expected to require a high percentage of ventricular pacing that cannot be managed with algorithms to minimize right ventricular pacing. these devices are indicated for the consulta crt-d model d224trk, concerto ii crt-d model d274trk, consulta crt-d model d204trm, protecta xt crt-d model d314trm, protecta crt-d model d334trm, protecta xt crt-d model d314trg, protecta crt-d model d334trg, viva xt crt-d model dtba1d4, viva xt crt-d model dtba1d1, viva s crt-d model dtbb1d4, and viva s crt-d model dtbb1d1:  for additional information please refer to the approval order.